Comparing antiplatelet and cholesterol-lowering therapy after heart stent
Part of Heart & circulation clinical trials.
This study compares different combinations of antiplatelet (blood-thinning for the stent) and cholesterol-lowering (statin) medicines after stent placement for a heart attack or unstable angina. The goal is to find the best way to prevent future heart problems and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 85 years old.
- You have had a mesh tube (stent) placed in a heart artery to treat a recent heart attack or unstable angina (chest pain at rest).
- You are not taking a blood thinner (like warfarin or apixaban) for other conditions.
- You have not had a serious allergic reaction or severe side effects from statin cholesterol medicines.
- You are not pregnant or planning to become pregnant during the study.
- You do not have severe muscle disease, underactive thyroid, heavy alcohol use, or severe liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of choosing blood thinners after a heart stent procedure. It aims to see if using an imaging-guided strategy leads to better outcomes than usual care.
This trial tests whether tailoring anti-platelet (blood clot prevention) treatment can better protect people at higher risk of heart or blood-vessel problems after a drug-eluting stent. It may help prevent future clots and complications, especially in patients with certain high-risk health conditions or complex stent/scar tissue features.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial compares two cholesterol-lowering treatment plans after a heart procedure where new drug-eluting stents were placed: a combination of high-intensity statin plus ezetimibe versus high-intensity statin alone. It may help find which option lowers cholesterol more effectively and safely over the first year after the procedure.
This trial compares two blood-thinning medicines—clopidogrel and aspirin—after you have finished a short period of dual therapy following a special type of drug-eluting heart stent. It may help find which medicine works better and is safer for preventing future heart problems.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.